Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10

Journal of Neuroimmunology

Volumn 126, Issue 1-2, 2002, Pages 16-24

  Kim, Woong Ki ^a   Ganea, Doina ^a   Jonakait, G Miller ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

B7 2; CD40; IFN ; IL 10; LPS; Microglia; PACAP

Indexed keywords

CD40 ANTIGEN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOWN REGULATION; IMMUNITY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SURFACE PROPERTY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD86; CELLS, CULTURED; GENE EXPRESSION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICROGLIA; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RNA, MESSENGER; T-LYMPHOCYTES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036090788     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00059-0     Document Type: Article

References (61)

1. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation
2. 2 secretion by microglia during antigen presentation to Th1 cells
3. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells
4. Regulation of inducible and neuronal nitric oxide synthase gene expression by interferon-γ and VIP
5. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia
6. CD40 engagement stimulates IL-12 p70 production by human microglial cells: Basis for Th1 polarization in the CNS
7. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
8. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus
9. Mature microglia resemble immature antigen-presenting cells
10. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT1 protein activation
11. Mechanisms of IL-10 production in human microglia-T cell interaction
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Following direct CD40 activation, human primary microglial cells produce IL-12 p40 but not bioactive IL-12 p70
14. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor κB and Ets activation
15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor α transcriptional activation by regulating nuclear factor-κB and cAMP response element-binding protein/c-Jun
16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: In vitro and in vivo studies
17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression
18. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells
19. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression
20. IL-10 down-regulates human microglial IL-8 by inhibition of NF-κB activation
21. Brain dendritic cells and macrophages/microglia in central nervous system inflammation
22. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
23. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
24. PACAP gene expression in neurons of the rat hypothalamo-pituitary-adrenocortical axis is induced by endotoxin and interleukin-1β
25. + T-cells
26. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-κB
27. Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells
28. Phenotypic plasticity in adult sympathetic ganglia in vivo: Effects of deafferentation and axotomy on the expression of vasoactive intestinal peptide
29. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo
30. Interleukin-10 inhibits expression of both interferon α- and interferon-γ-induced genes by suppressing tyrosine phosphorylation of STAT1
31. Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro
32. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-α production in injured spinal cord and in activated microglia via a cAMP-dependent pathway
33. Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide
34. Microglia induce myelin basic protein-specific T cell energy or T cell activation, according to their state of activation
35. 2 and cyclic AMP-elevating agents
36. Pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type 1 receptor expression in regenerating adult mouse and rat superior cervical ganglia in vitro
37. Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells
38. Involvement of STAT-1 and Ets family members in interferon-γ induction of CD40 transcription in microglia/macrophages
39. IL-4-activated STAT-6 inhibits IFN-γ-induced CD40 gene expression in macrophages/microglia
40. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-β
41. Accessory signaling by CD40 for T cell activation: Induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-γ production
42. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis
43. Identification of a silencer, enhancer, and basal promoter region in the human CD95 (Fas/APO-1) gene
44. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation
45. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture
46. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding
47. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis
48. Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons
49. IL-10 attenuates IFN-α-activated STAT1 in the liver: Involvement of SOCS2 and SOCS3
50. Activation of microglial cells by the CD40 pathway: Relevance to multiple sclerosis
51. Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation
52. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-α production that is opposed by TGF-β1 and IL-10
53. A new primate model for multiple sclerosis in the common marmoset
54. Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases
55. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions
56. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-β1 (TGF-β1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia
57. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment
58. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy
59. Expression of neuropeptides and neuropeptide mRNAs in spinal cord after axotomy in the rat, with special reference to motoneurons and galanin
60. Pituitary adenylate cyclase-activating peptide expression in the rat dorsal root ganglia: Up-regulation after peripheral nerve injury
61. Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus